Skip to main content
Go to the home page of the European Commission (opens in new window)
English English
CORDIS - EU research results
CORDIS

The disruptive personalized machine-based genetic counseling platform

Project description

Smart counsellor for genetics-based, personalised medicine

Personalised treatment based on genetic data is the future of medicine. However, there are only 7 000 professional genetical counsellors all over the world who can guide patients through related decisions. The most accurate solution is automated genetic counselling (GC). The EU-funded Igentify project aims to develop the world’s first ‘Digital Genetic Counsellor’ – a digital platform for genetic tests providers. It will offer a fully scalable counselling solution for both clinical and non-clinical genetic testing applications. It will also apply various genotyping technologies like a microarray and next-generation sequencing (NGS). With algorithms analysing all genetics related parameters, it automatically elaborates the individual profile of a patient. The ground-breaking audio-visual asset generation algorithm enables educative content for each patient.

Objective

The promise of personalized medicine will soon materialize. However, this revolution will require genetic counsellors as key professional to facilitate patients´ informed decision-making. However, there are just 7,000 worldwide, insufficient to fulfil the ever-growing demand for these services (>40 million people tested in 2018). Likewise, health care organizations cannot implement genetic counselling (GC) as a tool to help patients understand, adapt and adjust to the medical and psychological consequences of their genetic tests results. Innovative automated solutions are needed to fully exploit the benefits from the upcoming genomic revolution to overcome, not just the shortage but also expensive, time consuming and not scalable current GC approach.
At Igentify Ltd, an Israeli startup home to 32 highly-skilled individuals, we have created the first clinically-approved Igentify: A 4 module-based machine learning digital platform automating all stages from the GC process, starting from enrolment of the patient into the system, until the delivery of customized machine generated GC. Igentify incorporates 2 features simplifying and making scalable GC: (1) A set of algorithms analysing all genetic-related parameters (e.g. ethnicity, carrier frequency, medical history, lifestyle, etc.) to profile the individual as low or high-risk. (2) A revolutionary audio-visual asset generation algorithm that autonomously creates dynamic audio-visual content customized for patients, explaining all information in an educational way. We have commercial agreements with early adopters, including Northwell Health, Gene by Gene, Kaplan Medical Center or Meudehet, confirming Igentify´s business opportunity.
We expect to gain a 4% market share within the global genetic testing market (€16.7 billion valuation by 2024, CAGR of 12.2%, period 2018-2024). This will translate into a revenue of € 104.06 M in 2026 (ROI of 7.04) while creating 150 jobs.

Fields of science (EuroSciVoc)

CORDIS classifies projects with EuroSciVoc, a multilingual taxonomy of fields of science, through a semi-automatic process based on NLP techniques. See: The European Science Vocabulary.

You need to log in or register to use this function

Programme(s)

Multi-annual funding programmes that define the EU’s priorities for research and innovation.

Topic(s)

Calls for proposals are divided into topics. A topic defines a specific subject or area for which applicants can submit proposals. The description of a topic comprises its specific scope and the expected impact of the funded project.

Funding Scheme

Funding scheme (or “Type of Action”) inside a programme with common features. It specifies: the scope of what is funded; the reimbursement rate; specific evaluation criteria to qualify for funding; and the use of simplified forms of costs like lump sums.

SME-1 - SME instrument phase 1

See all projects funded under this funding scheme

Call for proposal

Procedure for inviting applicants to submit project proposals, with the aim of receiving EU funding.

(opens in new window) H2020-EIC-SMEInst-2018-2020

See all projects funded under this call

Coordinator

IGENTIFY LTD
Net EU contribution

Net EU financial contribution. The sum of money that the participant receives, deducted by the EU contribution to its linked third party. It considers the distribution of the EU financial contribution between direct beneficiaries of the project and other types of participants, like third-party participants.

€ 50 000,00
Address
14 HALMISH STREET
3088900 CAESAREA
Israel

See on map

SME

The organization defined itself as SME (small and medium-sized enterprise) at the time the Grant Agreement was signed.

Yes
Activity type
Private for-profit entities (excluding Higher or Secondary Education Establishments)
Links
Total cost

The total costs incurred by this organisation to participate in the project, including direct and indirect costs. This amount is a subset of the overall project budget.

€ 71 429,00
My booklet 0 0